டாகேடா மருந்துகள் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article WASHINGTON, Feb. 3, 2021 /PRNewswire/  Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected two new officers to its board of directors. Ramona Sequeira, president of Takeda Pharmaceuticals USA, Inc. was named chair-elect. Sequeira formerly held the position of board treasurer, and when she assumes the role of board chair next year, she ll be the first woman in PhRMA s history to do so. Additionally, PhRMA s board elected Vas Narasimhan, M.D., CEO of Novartis, to serve as board treasurer. PhRMA and the biopharmaceutical research companies we represent are focused on the critical issues that matter to the American people. We can help deliver the solutions that are needed to get COVID-19 under control, bring the economy back and make health care more affordable, said Stephen J. Ubl, president and CEO of PhRMA. I am confident that under the leadership of Ramona and Vas, as well as under Dave Ricks continued leader

United statesRamona sequeiraAmerica phDave rickEli lillyTakeda pharmaceuticals united states incMcmaster universityGlobal head of developmentGlobal head of drug developmentTakeda executive teamNational academy of medicineUniversity of torontoTakeda pharmaceuticals united statesa incPharmaceutical researchTakeda pharmaceuticals united statesVas narasimhan